Informationen:
Fehler:
ID
33921
Beschreibung
Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif; ODM derived from: https://clinicaltrials.gov/show/NCT02377323
Link
https://clinicaltrials.gov/show/NCT02377323
Stichworte
Versionen (1)
- 07.01.19 07.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
7. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Multiple Sclerosis NCT02377323
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Clinically isolated syndrome | Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
Item
patients with cis or definite ms (rrms or spms);
boolean
C2921627 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
Clinic Visit
Item
patients seen at our clinic within the last 2 years;
boolean
C0008952 (UMLS CUI [1])
Patients Untreated | Rebif Low dose | Rebif High dose
Item
patients untreated, or treated with either low dose or high dose rebif for at least two years;
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
Age
Item
patients between 18 to 60 years old at time of treatment initiation;
boolean
C0001779 (UMLS CUI [1])
EDSS
Item
edss ≤ 5.5 at treatment initiation;
boolean
C0451246 (UMLS CUI [1])
Able to read French language | Able to write French language
Item
patients able to read and write in french.
boolean
C0586740 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
Multiple Sclerosis, Primary Progressive
Item
patients diagnosed with primary progressive ms;
boolean
C0751964 (UMLS CUI [1])
Disease Modification Pharmaceutical Preparations | Exception Rebif
Item
patients treated with other dmd, other than rebif;
boolean
C0012634 (UMLS CUI [1,1])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
Comorbidity Influence Research results
Item
co-existence of other diseases that could influence outcomes.
boolean
C0009488 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])